quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:10:26·986d
INSIDERFiling
Sigilon Therapeutics Inc. logo

SEC Form 4: Kowalsky Matthew Paul returned 1,925 shares to the company, closing all direct ownership in the company

SGTX· Sigilon Therapeutics Inc.
Health Care
Original source

Companies

  • SGTX
    Sigilon Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Dec 23UpdateCanaccord Genuity$7.00
  • Dec 1UpdateBarclays$7.00
  • Nov 30UpdateMorgan Stanley$4.50
  • Nov 30UpdateJefferies$4.00
  • Oct 29UpdateBTIG$14.00
  • Aug 2UpdateJefferies$15.00

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by Sigilon Therapeutics Inc. (Amendment)
  • SEC976d
    SEC Form 15-12G filed by Sigilon Therapeutics Inc.
  • SEC982d
    SEC Form EFFECT filed by Sigilon Therapeutics Inc.
  • INSIDER982d
    SEC Form 4 filed by Flagship Ventures Fund V General Partner Llc
  • NEWS982d
    Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
  • 13D/G983d
    SEC Form SC 13D/A filed by Sigilon Therapeutics Inc. (Amendment)
  • INSIDER983d
    SEC Form 4: Eli Lilly & Co bought $25,639,916 worth of shares (1,718,493 units at $14.92)
  • PR983d
    Lilly Completes Acquisition of Sigilon Therapeutics
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022